Elevance Health | ANTM - Gewinn Vor Steuern

Aktienkurs
376.42
Täglich Wechseln
-0.21 -0.06%
Monatlich
28.58%
Jährlich
-7.81%
Q2 Prognose
337.38




Gewinn Vor Steuern Veränderung Datum
Acadia Healthcare USD -1.17B 1.21B 2025-12
Addus HomeCare USD 30.35M 405K 2025-09
Brookdale Senior Living USD -41.15M 73.42M 2025-12
Cardinal Health USD 630M 32M 2025-12
Centene USD 2.1B 3.64B 2026-03
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cigna USD 1.82B 478M 2025-12
Community Health Systems USD 52M 9M 2025-09
CVS Health USD 1.35B 4.84B 2025-12
DaVita Healthcare Partners USD 308.8M 60.13M 2025-09
eHealth USD -44.36M 15.89M 2024-09
Elevance Health USD 215M 1.19B 2025-12
Encompass Health USD 257.7M 37.8M 2025-12
Ensign USD 130.08M 23.48M 2025-12
HCA USD 2.67B 254M 2025-12
Humana USD -1.01B 1.54B 2025-12
IQVIA Holdings USD 537M 5.62B 2025-12
Laboratory Of America USD 190.6M 146.4M 2025-12
McKesson USD 1.4B 344M 2025-09
Molina Healthcare USD 29M 243M 2026-03
Pediatrix Medical Group USD -101.98M 162.6M 2025-09
Quest Diagnostics USD 334M 4M 2026-03
Select Medical USD 50.46M 5.46M 2025-12
Tenet Healthcare USD 681M 31M 2025-12
UnitedHealth USD -720M 3.95B 2025-12
Universal Health Services USD 581.44M 84.55M 2025-12
Veradigm USD 35.3M 13.95M 2022-09